Glycaemic control does not appear to correlate with mortality from COVID-19

Authors

  • Eunice O Wiafe York Teaching Hospital NHS foundation trust
  • Jagannath Gopalappa Diabetes and Endocrinolgy York Teaching Hospitals NHS Foundation Trust
  • Vijay Jayagopal York Teaching Hospitals NHS Foundation Trust

DOI:

https://doi.org/10.15277/bjd.2021.280

Keywords:

COVID-19, diabetes, deaths, HbA1c, glycaemic control

Author Biographies

Eunice O Wiafe, York Teaching Hospital NHS foundation trust

Specialty Registrar

Diabetes and Endocrinology Department

York Teaching Hospitals NHS Foundation Trust

Jagannath Gopalappa, Diabetes and Endocrinolgy York Teaching Hospitals NHS Foundation Trust

Consultant Endocrinologist

Diabetes and Endocrinolgy Unit
York Teaching Hospitals NHS Foundation Trust

Vijay Jayagopal, York Teaching Hospitals NHS Foundation Trust

Consultant Endocrinologist 

Diabetes and Endocrinology Department

York Teaching Hospitals NHS Foundation Trust.

References

GOV.UK. Deaths within 28 days of positive test. https://coronavirus.data.gov.uk/deaths (accessed 20 August 2020).

Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol 2020;8(9):782–92. https://doi.org/10.1016/S2213-8587(20)30238-2

Holman N, Knighton P, Kar P, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol 2020;8(10):823–33. https://doi.org/10.1016/S2213-8587(20)30271-0

Baron E, Bakhai C, Parthar K, et al. Association of type 1 and type 2 diabetes with COVID-19 related mortality in England: a whole population study. Lancet Diabetes Endocrinol 2020;8(10):813–22. https://doi.org/10.1016/S2213-8587(20)30272-2

Booth CM, Latukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003;289:2801–9. https://doi.org/10.1001/jama.289.21.JOC30885

Garbati MA, Fagbo SF, Fang VJ, et al. A comparative study of clinical presentation and risk factors for adverse outcome in patients hospitalised with acute respiratory disease due to MERS coronavirus or other causes. PLoS One 2016;11:e0165978. https://doi.org/10.1371/journal.pone.0165978

Schoen K, Horvat N, Guerreiro NFC, de Castro I, de Giassi KS. Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity. BMC Infect Dis 2019;19(1):964. https://doi.org/10.1186/s12879-019-4592-0

Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 2020; 109(5):531–8. https://doi.org/10.1007/s00392-020-01626-9

Fadini GP, Morieri ML, Longato E, Avogaro A. Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest 2020;43(6):867–9. https://doi.org/10.1007/s40618-020-01236-2

Downloads

Published

2021-05-28

Issue

Section

Letters to the editor